Youyuan Xia,Tong Su,Ziyi Mi,Ziyou Feng,Yawen Hong,Xiaoya Hu,Yun Shu
Non-invasive wearable sweat glucose sensors are expected to be highly desirable for personalized diabetes management. Therefore, developing facile, convenient, and scalable manufacturing method of such wearable sensors is urgently needed. Herein, we report a simple and low-cost stamping-vacuum filtration dry transfer (SVFDT) method for construction of a wearable sweat glucose electrochemical sensor. In this patch, a three-electrode array template was made by using a polyvinyl chloride (PVC) stamp, followed by the preparation of multiwalled carbon nanotubes (MWCNTs)/polydimethylsiloxane (PDMS) (MP) film electrode using the vacuum-filtration dry transfer method. In addition, for further enhancing the conductivity of the electrode, another similar stamp with a raised surface dipping carbon nanotubes (CNTs) conductive coating was stamped on the surface of the MP electrode to obtain CNTs/MWCNTs/PDMS (CMP) electrode. CMP electrode was modified with the enzyme-like Ni-Co metal-organic framework (MOF) material which showed good electro-catalytic activity and achieved high sensitivity for glucose detection with a low detection limit of 6.78 μM and a wide linear range of 20 μM - 1.1 mM. More importantly, the Ni-Co MOF modified CMP (NCMP) electrode also displayed high stability under stretching and bending conditions. Finally, the sweat absorbent cloth was combined with the NCMP film electrode to form a wearable flexible electrochemical sensor patch, which could adhere to the skin to enrich sweat and realize real-time detection of sweat glucose with high accuracy. This SVFDT method can also be applied to the fabrication of other electronic devices.
Chemotherapeutic drugs such as paclitaxel and vinblastine interact with microtubules and thus induce complex cell states of mitosis arrest at the G2/M phase followed by apoptosis dependent on drug exposure time and concentration. Microfluidic impedance cytometry (MIC), as a label-free and high-throughput technology for single-cell analysis, has been applied for viability assay of cancer cells post drug exposure at fixed time and dosage, yet verification of this technique for varied tumor cell states after anticancer drug treatment remains a challenge. Here we present a novel MIC device and for the first time perform impedance cytometry on carcinoma cells exhibiting progressive states of G2/M arrest followed by apoptosis related to drug concentration and exposure time, after treatments with paclitaxel and vinblastine, respectively. Our results from impedance cytometry reveal increased amplitude and negative phase shift at low frequency as well as higher opacity for HeLa cells under G2/M mitotic arrest compared to untreated cells. The cells under apoptosis, on the other hand, exhibit opposite changes in these electrical parameters. Therefore, the impedance features differentiate the HeLa cells under progressive states post anticancer drug treatment. We also demonstrate that vinblastine poses a more potent drug effect than paclitaxel especially at low concentrations. Our device is fabricated using a unique sacrificial layer-free soft lithography process as compared to the existing MIC device, which gives rise to readily aligned parallel microelectrodes made of silver-PDMS embedded in PDMS channel sidewalls with one molding step. Our results uncover the potential of the MIC device, with a fairly simple and low-cost fabrication process, for cellular state screening in anticancer drug therapy.
危险品化学品经营许可证（带存储）